Title |
PTENgenomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity
|
---|---|
Published in |
BMC Cancer, November 2012
|
DOI | 10.1186/1471-2407-12-543 |
Pubmed ID | |
Authors |
Khalil Choucair, Joshua Ejdelman, Fadi Brimo, Armen Aprikian, Simone Chevalier, Jacques Lapointe |
Abstract |
Prostate cancer (PCa), a leading cause of cancer death in North American men, displays a broad range of clinical outcome from relatively indolent to lethal metastatic disease. Several genomic alterations have been identified in PCa which may serve as predictors of progression. PTEN, (10q23.3), is a negative regulator of the phosphatidylinositol 3-kinase (PIK3)/AKT survival pathway and a tumor suppressor frequently deleted in PCa. The androgen receptor (AR) signalling pathway is known to play an important role in PCa and its blockade constitutes a commonly used treatment modality. In this study, we assessed the deletion status of PTEN along with AR expression levels in 43 primary PCa specimens with clinical follow-up. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 2% |
Canada | 1 | 2% |
Brazil | 1 | 2% |
Unknown | 54 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 15 | 26% |
Researcher | 10 | 18% |
Student > Bachelor | 9 | 16% |
Professor | 3 | 5% |
Student > Postgraduate | 3 | 5% |
Other | 11 | 19% |
Unknown | 6 | 11% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 18 | 32% |
Medicine and Dentistry | 14 | 25% |
Biochemistry, Genetics and Molecular Biology | 9 | 16% |
Nursing and Health Professions | 1 | 2% |
Unspecified | 1 | 2% |
Other | 2 | 4% |
Unknown | 12 | 21% |